Skip to main content
  • Home

Monthly archive

  • August 2012 (10)
  • July 2012 (31)
  • June 2012 (32)
  • May 2012 (12)
  • April 2012 (6)
  • March 2012 (20)
  • February 2012 (24)
  • January 2012 (8)
  • December 2011 (25)
  • November 2011 (5)
  • October 2011 (3)
  • September 2011 (1)
  • June 2011 (3)
Follow us:
  • facebook
  • twitter
  • YouTube

 

  • Popular
  • Recent
  • Tags
  • Warfarin alternatives create concerns

    • Jun 22, 2012
  • New tracking system may stunt prescription drug abuse

    • Jul 27, 2012
  • Investors file class action lawsuit against The Cooper Companies

    • Dec 22, 2011
  • Possible breast cancer risk for menopausal women on estrogen

    • Apr 3, 2012
  • Transvaginal mesh injures thousands of women

    • Feb 16, 2012
  • EMA recommends updated Pradaxa labels

    • May 29, 2012
  • FDA issues warning after codeine kills children post-surgery

    • Aug 16, 2012
  • Artificial retina gives sight to blind mice

    • Aug 16, 2012
  • Lucentis approved for diabetic macular edema

    • Aug 14, 2012
  • Mayo Clinic: Patients in the dark about prescriptions

    • Aug 9, 2012
  • Hospital's plan to prevent painkiller abuse

    • Aug 8, 2012
  • Alzheimer's drug disappoints

    • Aug 8, 2012
lawsuit Yaz dabigatran Nature heart attack Pradaxa kidney problems stroke type 2 diabetes Belviq lorcaserin pulomonary embolism blood thinner yo GlaxoSmithKline diet drug blood thinners Adderall coumadin Johnson & Johnson hormone replacement therapy Roche SSRI Warfarin Avaira diet pill Inspiration TVM metal on metal hip replacement Medicaid

More Dangerous Drug News

Lipitor Type 2 Diabetes Lawsuit

Get News Updates By Email

@ConsumerDrugRep Tweets

Archives

  • June 2011 (3)
  • September 2011 (1)
  • October 2011 (3)
  • November 2011 (5)
  • December 2011 (25)
  • January 2012 (8)
  • February 2012 (24)
  • March 2012 (20)
  • April 2012 (6)
  • May 2012 (12)

Pages

  • 1
  • 2
  • next ›
  • last »
Saturday, 26 September 2026
  • Subscribe by RSS
Consumer Drug Report
  • Tylenol
  • Miscellaneous
    • Avaira
  • Antidepressants
  • Fosamax
  • Pradaxa
  • Actos
  • Yaz
About Us

From side effects to recalls to pending lawsuits, Consumer Drug Report keeps you up to date with the latest information on pharmaceutical safety.

To submit questions or story ideas, please post on our Consumer Drug Report Facebook page,

tweet at us @ConsumerDrugRep, or

email us at news@consumer-drug-report.com.

Details

Home

About

Contact

Privacy

Sitemap 

Disclaimer

Categories
  • Actos
  • Antidepressants
  • Avaira
  • Fosamax
  • Miscellaneous
  • Pradaxa
  • Tylenol
  • Yaz

Brought to you by Spangenberg Shibley & Liber, LLP © 2012